United States

Top 1000 largest US Companies in the Healthcare sector by Market Cap

This is the list of the largest public listed companies in the Healthcare sector from the United States by market capitalization with links to their reference stock and industry.

United States Healthcare Sector Analysis
Top US Companies United States Analysis
World Top Companies World Companies Analysis

Top Healthcare Companies from the United States as of Jan. 01, 2026

Download Excel

Rank Company Market Cap (USD) Country Sector Industry
661 Passage Bio, Inc. $37.2 M United States US Healthcare US Biotechnology
662 Star Equity Holdings, Inc. $37.1 M United States US Healthcare US Medical Devices
663 FibroGen, Inc. $37.1 M United States US Healthcare US Biotechnology
664 Generation Bio Co. $36.7 M United States US Healthcare US Biotechnology
665 Reviva Pharmaceuticals Holdings, Inc. $36.2 M United States US Healthcare US Biotechnology
666 MariMed, Inc. $35.6 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
667 Lantern Pharma Inc. $34.8 M United States US Healthcare US Biotechnology
668 BIOQUAL, Inc. $34.4 M United States US Healthcare US Diagnostics & Research
669 Zivo Bioscience, Inc. $34.0 M United States US Healthcare US Biotechnology
670 Dyadic International, Inc. $34.0 M United States US Healthcare US Biotechnology
671 BioAtla, Inc. $31.4 M United States US Healthcare US Biotechnology
672 Angion Biomedica Corp $30.1 M

(June 1, 2023)

United States US Healthcare US Biotechnology
673 Marinus Pharmaceuticals, Inc. $29.9 M

(Jan. 1, 2025)

United States US Healthcare US Biotechnology
674 Vaso Corp $29.1 M United States US Healthcare US Health Information Services
675 Harvard Bioscience, Inc. $29.1 M United States US Healthcare US Medical Instruments & Supplies
676 Aytu BioScience, Inc. $28.2 M United States US Healthcare US Biotechnology
677 Athira Pharma, Inc. $27.4 M United States US Healthcare US Biotechnology
678 Cyclo Therapeutics, Inc. $26.9 M

(Jan. 1, 2025)

United States US Healthcare US Biotechnology
679 SCYNEXIS, Inc. $26.8 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
680 iAnthus Capital Holdings, Inc. $26.6 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
681 Onconova Therapeutics, Inc. $23.7 M United States US Healthcare US Biotechnology
682 Polarean Imaging plc $23.2 M

(July 1, 2025)

United States US Healthcare US Medical Devices
683 Vivos Therapeutics, Inc. $22.7 M United States US Healthcare US Medical Devices
684 Streamline Health Solutions, Inc. $22.6 M

(July 1, 2025)

United States US Healthcare US Health Information Services
685 Finch Therapeutics Group, Inc. $21.7 M United States US Healthcare US Biotechnology
686 Cano Health, Inc. $21.6 M

(Jan. 1, 2024)

United States US Healthcare US Medical Care Facilities
687 Yumanity Therapeutics, Inc. $20.5 M

(Dec. 1, 2022)

United States US Healthcare US Biotechnology
688 NeuroBo Pharmaceuticals, Inc. $20.3 M

(Jan. 1, 2025)

United States US Healthcare US Biotechnology
689 VYNE Therapeutics Inc. $19.3 M United States US Healthcare US Biotechnology
690 Metacrine, Inc. $18.8 M

(Jan. 1, 2023)

United States US Healthcare US Biotechnology

Top Healthcare Companies from the United States as of Jan. 01, 2026

661. Passage Bio, Inc.

Company Profile: Passage Bio, Inc.
Market Cap (USD): $37.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

662. Star Equity Holdings, Inc.

Company Profile: Star Equity Holdings, Inc.
Market Cap (USD): $37.1 M
Country: United States
Sector: US Healthcare
Industry: US Medical Devices

663. FibroGen, Inc.

Company Profile: FibroGen, Inc.
Market Cap (USD): $37.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

664. Generation Bio Co.

Company Profile: Generation Bio Co.
Market Cap (USD): $36.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

665. Reviva Pharmaceuticals Holdings, Inc.

Company Profile: Reviva Pharmaceuticals Holdings, Inc.
Market Cap (USD): $36.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

666. MariMed, Inc.

Company Profile: MariMed, Inc.
Market Cap (USD): $35.6 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

667. Lantern Pharma Inc.

Company Profile: Lantern Pharma Inc.
Market Cap (USD): $34.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

668. BIOQUAL, Inc.

Company Profile: BIOQUAL, Inc.
Market Cap (USD): $34.4 M
Country: United States
Sector: US Healthcare
Industry: US Diagnostics & Research

669. Zivo Bioscience, Inc.

Company Profile: Zivo Bioscience, Inc.
Market Cap (USD): $34.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

670. Dyadic International, Inc.

Company Profile: Dyadic International, Inc.
Market Cap (USD): $34.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

671. BioAtla, Inc.

Company Profile: BioAtla, Inc.
Market Cap (USD): $31.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

672. Angion Biomedica Corp

Company Profile: Angion Biomedica Corp
Market Cap (USD): $30.1 M (June 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

673. Marinus Pharmaceuticals, Inc.

Company Profile: Marinus Pharmaceuticals, Inc.
Market Cap (USD): $29.9 M (Jan. 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

674. Vaso Corp

Company Profile: Vaso Corp
Market Cap (USD): $29.1 M
Country: United States
Sector: US Healthcare
Industry: US Health Information Services

675. Harvard Bioscience, Inc.

Company Profile: Harvard Bioscience, Inc.
Market Cap (USD): $29.1 M
Country: United States
Sector: US Healthcare
Industry: US Medical Instruments & Supplies

676. Aytu BioScience, Inc.

Company Profile: Aytu BioScience, Inc.
Market Cap (USD): $28.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

677. Athira Pharma, Inc.

Company Profile: Athira Pharma, Inc.
Market Cap (USD): $27.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

678. Cyclo Therapeutics, Inc.

Company Profile: Cyclo Therapeutics, Inc.
Market Cap (USD): $26.9 M (Jan. 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

679. SCYNEXIS, Inc.

Company Profile: SCYNEXIS, Inc.
Market Cap (USD): $26.8 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

680. iAnthus Capital Holdings, Inc.

Company Profile: iAnthus Capital Holdings, Inc.
Market Cap (USD): $26.6 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

681. Onconova Therapeutics, Inc.

Company Profile: Onconova Therapeutics, Inc.
Market Cap (USD): $23.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

682. Polarean Imaging plc

Company Profile: Polarean Imaging plc
Market Cap (USD): $23.2 M (July 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Medical Devices

683. Vivos Therapeutics, Inc.

Company Profile: Vivos Therapeutics, Inc.
Market Cap (USD): $22.7 M
Country: United States
Sector: US Healthcare
Industry: US Medical Devices

684. Streamline Health Solutions, Inc.

Company Profile: Streamline Health Solutions, Inc.
Market Cap (USD): $22.6 M (July 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Health Information Services

685. Finch Therapeutics Group, Inc.

Company Profile: Finch Therapeutics Group, Inc.
Market Cap (USD): $21.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

686. Cano Health, Inc.

Company Profile: Cano Health, Inc.
Market Cap (USD): $21.6 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Medical Care Facilities

687. Yumanity Therapeutics, Inc.

Company Profile: Yumanity Therapeutics, Inc.
Market Cap (USD): $20.5 M (Dec. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

688. NeuroBo Pharmaceuticals, Inc.

Company Profile: NeuroBo Pharmaceuticals, Inc.
Market Cap (USD): $20.3 M (Jan. 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

689. VYNE Therapeutics Inc.

Company Profile: VYNE Therapeutics Inc.
Market Cap (USD): $19.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

690. Metacrine, Inc.

Company Profile: Metacrine, Inc.
Market Cap (USD): $18.8 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Stay in touch